Nuclear Medicine
TERABAC
Name:
Terabac
Active Principle:
Sodium Iodide (131I)
Therapeutic Action:
It is indicated for the treatment of hyperthyroidism (diffuse toxic goiter or nodular multiple toxic goiter). Diagnosis:
– For the pre-therapeutic determination of the kinetics of radioactive iodine (determination of the storage and effective half-life in the thyroid gland by means of a two-phase radioactive iodine test)
– Calculation of the activity necessary for therapy. – Whole body scintigraphy for the follow-up of papillary or follicular thyroid carcinomas. Therapy
– Therapy of focal or disseminated Graves’ disease and thyroid autonom
– Therapy of papillary or follicular thyroid carcinomas and their metastases Sodium iodide (131I) therapy is often combined with surgical measures and a thyrostat in a combination treatment.
Línea
Nuclear Medicine
Sublínea
Radiation Therapy
TERABAC
Línea
Nuclear Medicine
Sublínea
Radiation Therapy
TERABAC
Nuclear Medicine
TERABAC
Name:
Terabac
Active Principle:
Sodium Iodide (131I)
Therapeutic Action:
It is indicated for the treatment of hyperthyroidism (diffuse toxic goiter or nodular multiple toxic goiter). Diagnosis:
– For the pre-therapeutic determination of the kinetics of radioactive iodine (determination of the storage and effective half-life in the thyroid gland by means of a two-phase radioactive iodine test)
– Calculation of the activity necessary for therapy. – Whole body scintigraphy for the follow-up of papillary or follicular thyroid carcinomas. Therapy
– Therapy of focal or disseminated Graves’ disease and thyroid autonom
– Therapy of papillary or follicular thyroid carcinomas and their metastases Sodium iodide (131I) therapy is often combined with surgical measures and a thyrostat in a combination treatment.
RELATED PRODUCTS
-
STANNOUS CHLORIDE
STANNOUS CHLORIDEIt is indicated for: - Performing scintigraphic studies of the blood pool of the heart and great vessels. - Circulatory and placental studies. - Evaluation of gastrointestinal bleeding (especially to locate... -
123I MIBG BACON (R&D)
123I MIBG BACON (R&D)It is indicated for: Oncology: a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest... -
131I MIBG BACON (R&D)
131I MIBG BACON (R&D)It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas...